About
About Tekla Healthcare Investors
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. Abrdn Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.
Visit company website
5 years, 4 months ago
Tekla Healthcare Investors is currently in a long term uptrend where the price is trading 9.6% above its 200 day moving average.
From a valuation standpoint, the stock is 50.4% cheaper than other stocks from the Financial Services sector with a price to sales ratio of 4.5.
Tekla Healthcare Investors's total revenue rose by 29.1% to $5M since the same quarter in the previous year.
Its net income has increased by 178.9% to $48M since the same quarter in the previous year.
Based on the above factors, Tekla Healthcare Investors gets an overall score of 4/5.